ADULT SOLID TUMOR
Clinical trials for ADULT SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ADULT SOLID TUMOR trials appear
Sign up with your email to follow new studies for ADULT SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo aims to boost lung cancer treatment response
Disease control Recruiting nowThis study tests whether adding the experimental drug visugromab to standard chemotherapy and immunotherapy can shrink tumors better than placebo in people with newly diagnosed metastatic non-squamous non-small cell lung cancer. About 107 adults who have not had prior treatment f…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated May 17, 2026 04:09 UTC
-
New drug cocktail aims to shrink lung tumors in Late-Stage trial
Disease control Recruiting nowThis study tests whether adding the experimental drug visugromab to standard immunotherapy and chemotherapy can shrink tumors better than chemotherapy alone in people with advanced non-squamous lung cancer. About 131 participants who have already tried one prior treatment will re…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New pill targets Hard-to-Treat cancers with specific gene mutation
Disease control Recruiting nowThis early-phase study tests a new oral drug, DO-2, in adults with advanced solid tumors (like lung cancer) that have a specific MET gene change and no standard treatment options left. The main goal is to check the drug's safety and find the right dose. About 55 participants will…
Matched conditions: ADULT SOLID TUMOR
Phase: PHASE1 • Sponsor: DeuterOncology • Aim: Disease control
Last updated May 04, 2026 16:17 UTC